Windtree Therapeutics, recently made waves by announcing plans to allocate up to $700 million toward acquiring BNB.

BNB/USDhits a fresh all-time high on positive developments. It hits a high of $855 and is currently trading around $851.50.

The rebound was fueled by Windtree Therapeutics' commitment to invest $520 million in BNB for its corporate treasury.

BNB (BNB) price is down slightly to trade at $771 on Friday, after correcting from its new record high of $809, reached on ...

After expanding into real estate and waste management in its search for new revenue opportunities to boost stock value, ...

Nasdaq-listed biotech company Windtree Therapeutics (WINT) announced it has signed a $500 million equity line of credit (ELOC ...

BNB's price rose over 6.6% in 24 hours, driven by corporate treasury purchases and a new trade deal between the US and EU.

Biotech firm Windtree plans $520M Binance Coin bet via stock deals and credit line, pending shareholder approval amid mixed ...

Nasdaq-listed Windtree Therapeutics will raise $520 million through an equity line of credit and a stock purchase agreement, ...

"We are excited to incorporate these new facilities to enable our future BNB acquisitions as part of our BNB treasury strategy," stated Jed Latkin, CEO of Windtree. "Pending stockholder approval, the ...

Windtree Therapeutics' latest move goes beyond its surprising forays into real estate and waste management, as the company ...